Akorn, Inc. and Strides Arcolab Ltd. have agreed to fund, develop, and commercialize an additional 10 ANDA injectable drug products for their Akorn-Strides, LLC Joint Venture. The two companies created the JV in 2005 and have since submitted 15 ANDAs. Before the end of the year, the JV expects to submit two more ANDAs. Akorn-Strides is developing liquid, lyophilized and dry powder fill generic injectable products targeting several therapeutic markets with a major focus on anti-infectives, analge...